EASYTRAK® 2 IS-1 4542 (UDI 00802526410901)Recalls & reported problems
Boston Scientific Corporation · Coronary Venous Steroid-Eluting Bipolar Pace/Sense Lead · Class 3 · Implant
All models of EASYTRAK 2 IS-1 (6)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
Quick summary
This Boston Scientific EASYTRAK 2 heart lead has 535 adverse event reports, with 3 deaths and 430 injuries. The reports often describe high electrical resistance, failure to pace the heart, wire fractures and leads moving out of place, and many mention infections that led to the lead being removed. No recalls name this device.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 536
- Deaths reported
- 3
- Injuries reported
- 429
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 536 adverse event reports that list this exact device (DI 00802526410901), received between Jul 6, 2015 and Sep 17, 2026 — classified as 3 deaths, 429 injuries, 104 malfunctions.
The most frequently reported specific device problem is “High impedance” (202 reports).
19 other recalls cover devices cleared under the same FDA submission (P010012); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- High impedance202
- Failure to Capture150
- Adverse Event Without Identified Device or Use Problem144
- Fracture89
- High Capture Threshold83
- Device Dislodged or Dislocated43
- Material Integrity Problem42
- Capturing Problem32
Patient problems
- No Clinical Signs, Symptoms or Conditions146
- Unspecified Infection133
- No Known Impact Or Consequence To Patient102
- No Consequences Or Impact To Patient85
- No Code Available46
- Sepsis36
- Muscle Stimulation14
- Device Overstimulation of Tissue10
Recent adverse event reports
The 25 most recent of 536 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 17, 2026Failure to Capture; High impedance; High Capture Threshold
It was reported that this cardiac resynchronization therapy defibrillator (CRT-D) and left ventricular (LV) lead exhibited pacing impedance measurements that were high and out of range, as well as loss of capture (LOC). It was noted that evaluation of the LV lead for possible replacement was planned. The patient was programmed to right ventricular (RV) only pacing. This CRT-D and LV lead remain in service. No adverse patient effects were reported.
Patient problems: Inflammation; Swelling/ Edema
MAUDE report 50797943 ↗InjuryAug 20, 2026Adverse Event Without Identified Device or Use Problem
It was reported that this left ventricular (LV) lead was surgically abandoned due to an unknown reason. A new lead was implanted. No additional adverse patient effects were reported.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50336820 ↗InjuryAug 11, 2026Adverse Event Without Identified Device or Use Problem
It was reported that this left ventricular (LV) lead was part of a system revision due to infection with sepsis. The patient was treated with intravenous antibiotics. There was no additional adverse patient effects reported. The LV lead was explanted.
Patient problems: Unspecified Infection
MAUDE report 50208517 ↗MalfunctionJun 30, 2026Failure to Capture; High impedance
IT WAS REPORTED THAT THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM EXHIBITED A SUDDEN RISE ON PACING IMPEDANCE MEASUREMENTS, REACHING HIGH OUT OF RANGE VALUES GREATER THAN 3000 OHMS ON THE LEFT VENTRICULAR (LV) CHANNEL. TECHNICAL SERVICES (TS) RECOMMENDED PROGRAMMING ENHANCEMENTS. THIS LV LEAD REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25673608 ↗MalfunctionJun 25, 2026Failure to Capture; Fracture
IT WAS REPORTED THAT THE PHYSICIAN SUSPECTED THAT THIS LEFT VENTRICULAR (LV) LEAD HAD FRACTURED AND WAS CONCERNED ABOUT POTENTIAL LOSS OF CAPTURE. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONTACTED AND WAS UNABLE TO DETERMINE IF THE LV LEAD WAS TRULY CAPTURING OR NOT. THEREFORE, TS RECOMMENDED THAT THE PATIENT BE EVALUATED IN-CLINIC TO ENSURE ADEQUATE CAPTURE. AT THIS TIME, THIS LV LEAD REMAINS IMPLANTED AND IN-SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25630314 ↗InjuryJun 24, 2026High impedance
It was reported that this left ventricular (LV) lead exhibited a high out of range pacing impedance, greater than 3000 Ohms. It was noted the patient had some other medical issues. No LV vectors were viable, subsequently, this LV lead was programmed off. This LV lead remains in situ. No additional adverse patient effects were reported.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25610801 ↗InjuryJun 10, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE LV LEAD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25463909 ↗InjuryMay 18, 2026Failure to Capture
IT WAS REPORTED THAT THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AND LEFT VENTRICULAR (LV) LEAD EXHIBITED LOSS OF CAPTURE (LOC). TECHNICAL SERVICES (TS) REVIEWED AND PROVIDED TROUBLESHOOTING OPTIONS. SUBSEQUENTLY, THE CRT-D WAS EXPLANTED AND REPLACED, WHILE THE LV REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25211814 ↗InjuryMay 18, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE LEAD WAS PART OF THE SYSTEM REVISION DUE TO INFECTION. THE PATIENT ADVOCATE WAS REFERRED TO THE PHYSICIAN. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE IMPLANTABLE LEAD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25208744 ↗InjuryMay 7, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS PREVIOUSLY CAPPED LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THIS PREVIOUSLY CAPPED LV LEAD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 25111166 ↗InjuryApr 30, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE LEAD WAS PART OF THE SYSTEM REVISION DUE TO INFECTION. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE IMPLANTABLE LEAD WAS SURGICALLY ABANDONED.
Patient problems: Unspecified Infection
MAUDE report 25043202 ↗InjuryApr 29, 2026Fracture; High impedance
IT WAS REPORTED THAT THIS LV LEAD EXHIBITED AN IMPEDANCE MEASUREMENT OF MORE THAN 3000 OHMS DUE TO VISIBLE CONDUCTOR CABLE FRACTURE WHICH WAS OBSERVED IN THE POCKET. THIS LV LEAD WAS SURGICALLY ABANDONED AND REPLACE WITH A DIFFERENT MODEL. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25027826 ↗InjuryApr 22, 2026Failure to Capture; Fracture
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS SURGICALLY ABANDONED DUE TO FRACTURE AND NO CAPTURE. A NEW LEAD WITH DIFFERENT MODEL WAS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24957400 ↗InjuryApr 22, 2026Failure to Capture; High impedance; Material Integrity Problem; Insufficient Device Problem Information
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS EXPLANTED DUE TO A PRODUCT PERFORMANCE ISSUE. A NEW DEVICE WAS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24956112 ↗InjuryMar 9, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT WITH THIS PREVIOUSLY CAPPED LEFT VENTRICULAR (LV) LEAD HAD AN INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE PREVIOUSLY CAPPED LV LEAD REMAINS CAPPED.
Patient problems: Unspecified Infection
MAUDE report 24551816 ↗InjuryMar 6, 2026Use of Device Problem; Connection Problem
IT WAS REPORTED THAT INTERROGATION OF THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM WAS UNSUCCESSFUL, AND THIS CRT-D HAD REACHED THE EXPLANT INDICATOR IN (B)(6) 2024. REVIEW OF DEVICE SETTINGS NOTED LOW OUT-OF-RANGE PACE IMPEDANCE MEASUREMENTS LESS THAN 200 OHMS FOR MORE THAN A YEAR ON THE RIGHT VENTRICULAR (RV) LEAD, WHICH WAS PURPOSEFULLY CONNECTED TO THE LEFT VENTRICULAR (LV) PORT AT THE LAST DEVICE REPLACEMENT PROCEDURE. ADDITIONAL INFORMATION RECEIVED REPORTED THAT THE RV LEAD IMPEDANCE ISSUE WAS KNOWN AT THE PREVIOUS DEVICE CHANGEOUT, AND THE RV AND LV LEADS WERE PURPOSEFULLY SWITCHED IN THE HEADER DURING THE BATTERY REPLACEMENT PROCEDURE FOR THIS REASON. AT THIS TIME, THERE ARE NO OTHER PLANS FOR INTERVENTION, OTHER THAN THE UPCOMING BATTERY REPLACEMENT. THIS LV LEAD REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24537246 ↗InjuryMar 4, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION AND EROSION. THE SYSTEM WAS REPORTEDLY PLANNED FOR EXPLANT. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THIS LV LEAD REMAINS IN SERVICE.
Patient problems: Erosion; Unspecified Infection
MAUDE report 24513186 ↗MalfunctionFeb 11, 2026Material Integrity Problem
IT WAS REPORTED THAT DURING A ROUTINE GENERATOR REPLACEMENT, IT WAS OBSERVED THAT THE INSULATION OF THE IMPLANTABLE LEAD HAD SUSTAINED DAMAGE DUE TO AN ACUTE BEND IN THE LEAD. DESPITE THIS FINDING, ALL LEAD FUNCTIONS WERE STABLE. THE PHYSICIAN OPTED TO RETAIN THE EXISTING LEAD AND WILL MONITOR FOR ANY FUTURE COMPLICATIONS. THE PATIENT IS SCHEDULED FOR REGULAR FOLLOW-UP APPOINTMENTS. THE LEAD REMAINS IN SERVICE, AND NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24311529 ↗MalfunctionJan 12, 2026Signal Artifact/Noise; Failure to Capture; High impedance; Over-Sensing; Material Integrity Problem
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED NOISY SIGNALS, CROSSTALK OVERSENSING, OUT OF RANGE PACING IMPEDANCES WITH MEASUREMENTS GREATER THAN 3000 OHMS, AND LOSS OF CAPTURE. TECHNICAL SERVICES (TS) REVIEWED THE AVAILABLE DATA AND CONFIRMED THESE OBSERVATIONS. TS ALSO NOTED THAT THE HEADER HAS THE LATEST ENHANCEMENTS DESIGNED TO MINIMIZE SPRING CONTACT RELATED ISSUES, MAKING A CONNECTION PROBLEM UNLIKELY. FURTHER IN CLINIC EVALUATION WAS RECOMMENDED. NO ADVERSE PATIENT EFFECTS WERE REPORTED, AND THIS LV LEAD REMAINS IN SERVICE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24036205 ↗InjuryJan 5, 2026Failure to Capture; High impedance; High Capture Threshold
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD EXHIBITED PACE IMPEDANCE MEASUREMENTS OF GREATER THAN 3,000 OHMS. THRESHOLD AT 7.5 VOLTS SHOWED NO CAPTURE. TECHNICAL SERVICES (TS) NOTED IT SOUNDED LIKE THIS LV LEAD WAS NOT FUNCTIONING AND HAD THE HEALTH CARE PROFESSIONAL (HCP) PROGRAM THE DEVICE TO RIGHT VENTRICULAR (RV) ONLY AS THERE WERE MINIMUM LV OUTPUTS, BIVENTRICULAR PACING OFF AND DAILY MEASUREMENTS OFF. THIS LV LEAD REMAINS IMPLANTED AT THIS TIME. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23957002 ↗InjuryDec 20, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE LEAD WAS PART OF THE SYSTEM REVISION DUE TO INFECTION. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE IMPLANTABLE LEAD WAS EXPLANTED.
Patient problems: Unspecified Infection
MAUDE report 23858445 ↗InjuryDec 2, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS PREVIOUSLY CAPPED LEFT VENTRICULAR (LV) LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE PREVIOUSLY CAPPED LV LEAD REMAINS CAPPED.
Patient problems: Unspecified Infection
MAUDE report 23698381 ↗InjuryNov 7, 2025Failure to Capture; Defective Device; Failure to Capture; Defective Device
IT WAS REPORTED THAT THIS LEFT VENTRICULAR (LV) LEAD WAS SURGICALLY ABANDONED DUE TO A PRODUCT PERFORMANCE ISSUE. THE REPLACEMENT PROCEDURE WAS SUCCESSFULLY PERFORMED AND A NEW LEAD WAS IMPLANTED INSTEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED OUTSIDE THE REVISION PROCEDURE. ADDITIONAL INFORMATION WAS RECEIVED THAT THIS LV LEAD WAS SURGICALLY ABANDONED DUE TO LOSS OF CAPTURE (LOC). NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23501507 ↗InjuryOct 31, 2025Defective Device; High Capture Threshold; Defective Device; High Capture Threshold
IT WAS REPORTED THAT THIS LEAD WAS SURGICALLY ABANDONED AND REPLACED DUE TO AN UNKNOWN PRODUCT PERFORMANCE ISSUE AT THIS TIME. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23438662 ↗InjuryOct 30, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT WITH THIS LEFT VENTRICULAR (LV) LEAD EXPERIENCED MUSCLE STIMULATION. THE LEAD WAS LATER EXPLANTED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Device Overstimulation of Tissue
MAUDE report 23423991 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P010012. One submission often covers many models, so check the product and lot details in each record.
- Z-1671-2022 · Jul 7, 2022 · Open, ClassifiedThe PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all
- Z-0081-2018 · Oct 4, 2017 · TerminatedRESONATE X4 CRT-D, Model G447, Sterile.
- Z-0080-2018 · Oct 4, 2017 · TerminatedMOMENTUM X4 CRT-D, Model G138, Sterile.
- Z-0079-2018 · Oct 4, 2017 · TerminatedVIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharma
- Z-1556-2010 · Mar 15, 2010 · TerminatedBoston Scientific LIVIAN Cardiac Resynchronization Therapy Defibrillator (CRT-D), models H220, H225, H227, H229. The LIVIAN family of cardiac resynchronization therapy defibrillat
- Z-0609-2010 · Dec 1, 2009 · TerminatedBoston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. the following models are not available in the US: models N106, N107, P106, P107,
- Z-1052-2007 · Mar 23, 2007 · TerminatedVITALITY AVT (model A155). Implantable Cardioverter Defibrillator. Atrial and Ventricular Therapies. Guidant Corporation Cardiac Rhythm Management, 4100 Hamline Avenue North, St. P
- Z-1049-2007 · Mar 23, 2007 · TerminatedCONTAK RENEWAL 3 RF (model H210, H215), CONTAK RENEWAL 3 RF HE (model H217, H219) cardiac resynchronization therapy defibrillator (CRT-D).
- Z-1047-2007 · Mar 23, 2007 · TerminatedCONTAK RENEWAL 3 (model H170, H175) CONTAK RENEWAL 3 HE (model H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Avenue North,
- Z-1053-2007 · Mar 23, 2007 · TerminatedVITALITY 2 (model T165, T175), VITALITY DS (model T125, T135), VITALITY EL (model T127), Implantable Cardioverter Defibrillators (ICD), are designed to detect and terminate ventric
- Z-1054-2007 · Mar 23, 2007 · TerminatedVITALITY DR HE Implantable Cardioverter Defibrillator (model T180). Sterile EO. Guidant Corporation, Cardiac Rhythm Management, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 U
- Z-1055-2007 · Mar 23, 2007 · TerminatedVITALITY 2 EL DR/VR (model T167, T177). contents have been sterilized with gaseous ethylene oxide. The Guidant Vitality 2 ICD, implantable cardioverter defibrillators, are design
- Z-0047-2008 · Mar 16, 2007 · TerminatedGuidant VITALITY VR/DR, Implantable Cardioverter Defibrillator, ICD, Models 1870 and 1871. Guidant VITALITY DR+, Implantable Cardioverter Defibrillator, ICD, Model 1872.
- Z-1288-06 · May 15, 2006 · TerminatedGuidant CONTAK RENEWAL 3 (models H170, H175) CONTAK RENEWAL 3 HE (models H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Guidant Corporation, 4100 Hamline Ave
- Z-0825-06 · Apr 7, 2006 · TerminatedGuidant CONTAK RENEWAL 3 (models H170,H175) CONTAK RENEWAL 3 HE (models H177, H179) Cardiac Resynchronization Therapy Defibrillator (CRT-D). Sterile EO. Guidant Corporation, 4100
…and 4 more.
Other Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) devices
- Gallant™ CDHFA500QSt. Jude Medical, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)2 recalls58 deaths8,401 reports
- Quartet™ 1458Q-86St. Jude Medical, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)207 deaths6,631 reports
- QUADRA ASSURA MP™ CD3369-40QSt. Jude Medical, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)103 deaths6,084 reports
- VIGILANT™ X4 CRT-D G247Boston Scientific Corporation · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)17 deaths2,066 reports
- Quadra Assura™ CD3365-40QSt. Jude Medical, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)53 deaths2,056 reports
- Cobalt™ XT HF Quad CRT-D MRI SureScan™ DTPA2QQMedtronic, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)4 recalls40 deaths1,639 reports
- Unify Assura™ CD3357-40QSt. Jude Medical, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)54 deaths1,784 reports
- Unify Assura™ CD3357-40CSt. Jude Medical, Inc. · Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)56 deaths1,588 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page